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family of transcription factors identified by their ability to
enforce skeletal muscle differentiation upon a wide variety
of nonmuscle cell types. In this study the mouse germline
MRF4 gene was disrupted by targeted recombination.
Animals homozygous for the MRF4bh1 allele, a deletion of
the functionally essential bHLH domain, displayed
defective axial myogenesis and rib pattern formation, and
they died at birth. Differences in somitogenesis between
homozygous MRF4bh1 embryos and their wild-type litter-
mates provided evidence for three distinct myogenic regu-
latory programs (My1-My3) in the somite, which correlate
temporally and spatially with three waves of cellular
recruitment to the expanding myotome. The first program
(My1), marked initially by Myf-5 expression and followed
by myogenin, began on schedule in the MRF4bh1/bh1
embryos at day 8 post coitum (E8). A second program
(My2) was highly deficient in homozygous mutant MRF4
embryos, and normal expansion of the myotome failed.
Moreover, expression of downstream muscle-specific
genes, including FGF-6, which is a candidate regulator of
inductive interactions, did not occur normally. The onset
of MyoD expression around E10.5 in wild-type embryos
marks a third myotomal program (My3), the execution of
which was somewhat delayed in MRF4 mutant embryos
but ultimately led to extensive myogenesis in the trunk. By
E15 it appeared to have largely compensated for the
defective My2 program in MRF4 mutants. Homozygous
MRF4bh1 animals also showed improper rib pattern
formation perhaps due to the absence of signals from cells
expressing the My2 program. Finally, a later and relatively
mild phenotype was detected in intercostal muscles of
newborn animals. 
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SUMMARYINTRODUCTION
In diverse developmental pathways, including skeletal myo-
genesis in vertebrates, specific sets of basic helix-loop-helix (b-
HLH) class transcription factors form regulatory networks
important for cell fate specification and/or terminal differen-
tiation (reviewed by Jan and Jan, 1993). In mammals, the MRF
(muscle regulatory factor) group includes MyoD, myogenin,
Myf-5 and MRF4/herculin/Myf-6, (reviewed by Weintraub,
1993) and together they compose the core of the myogenic
bHLH net. Evidence from several lines of investigation have
led to the view that these genes are individually and collec-
tively important for muscle determination and differentiation.
Both in tissue culture cells (reviewed by Olson, 1990) and
transgenic animals (Hopwood and Gurdon, 1990; Miner et al.,
1992), dominant gain of function assays have shown that each
MRF can activate muscle-specific genes and, in permissive cell
environments, drive wholesale conversion of the host cells to
a myocyte-like phenotype. At the molecular level, MRFs are
sequence-specific DNA binding proteins that bind to function-ally important sites in the enhancers of many muscle-specific
genes (Murre et al., 1989; Weintraub et al., 1991). In vivo,
MRF expression is largely restricted to skeletal muscle pre-
cursors and mature myofibers (Buckingham, 1992), consistent
with functions specific to myogenesis. Finally, germline gene
disruption experiments in the mouse are now providing
stringent in vivo tests of inferences from prior expression and
molecular studies. So far, these experiments have shown that
MyoD and Myf-5 are jointly important for formation and/or
survival of muscle precursor populations (Rudnicki et al.,
1993), while myogenin is needed for efficient and proper
muscle differentiation in vivo (Hasty et al., 1993; Nabeshima
et al., 1993). In addition to these myogenic phenotypes, null
alleles of Myf-5 (Braun et al., 1992) and myogenin also affected
axial skeletogenesis, disrupting to different degrees distal rib
formation. Here, we describe disruption of the mouse MRF4
gene.
All known skeletal muscle in an adult vertebrate originates
from cells of the dorsal prechordal and paraxial mesoderm
(Wachtler and Christ, 1992). In the trunk and tail regions, this
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in a rostrocaudal progression on both sides of the neural tube.
Under the influence of signals from epidermis, neural tube and
notochord, these somites subdivide into dermamyotome
(muscle and skin precursors) and sclerotome (cartilage and
bone precursors), and subsequently the dermamyotome further
segregates into myotome and dermatome. Within the develop-
ing dermamyotome and myotome, there is a dynamic pattern
of MRF expression such that each MRF is expressed in a dis-
tinctive spatiotemporal pattern that generally overlaps with
expression of one or more other family members (reviewed,
Buckingham, 1992; Smith et al., 1994). The pattern for MRF4
is different from the others in three major respects. First, its
myotomal expression occurs in a discrete wave that begins at
about day 9 post coitum (E9) and ends at around E11.5, while
the others continue to be expressed significantly until at least
E15 when the axial muscle masses derived from the myotome
are quite well defined. Second, MRF4 is not involved in early
myogenesis in the head or limb musculature but the other three
MRFs are. Finally, MRF4 expression initiates a second wave
at E16 and ultimately comes to dominate quantitatively over
the other MRFs in adult muscle, an observation that led to the
suggestion that MRF4 may be needed to maintain the differ-
entiated skeletal phenotype (Miner and Wold, 1990).
In this work, disruption of the MRF4 gene produced both
muscle and skeletal abnormalities in the mouse embryo and
fetus. Molecular and cytological analysis of homozygous
mutant MRF4bh1 embryos showed that early and late waves of
myogenic commitment and differentiation in the myotome
occurred similarly in mutant and wild-type myotomes, but an
intermediate myotomal expansion during the period of somitic
MRF4 expression (approx. E9-11) failed. These observations,
considered together with patterns of MRF expression and their
respective mutant phenotypes, led us to propose a new model
for myotome formation in which each of three myotomal MRF
programs (My1-My3) drives a distinct wave of myotomal
cellular expansion. In this model, different combinations of
MRFs are required for execution of each wave of commitmentTable 1. Primers 
Gene Forward primer 
MRF4 CTACATTGAGCGTCTACAGGACC
Myf-5 TGAATGTAACAGCCCTGTCTGGTC
MyoD* AGGCTCTGCTGCGCGACC
myogenin* GAGCGCGATCTCCGCTACAGAGG
FGF6 GTGCTCTCTTCATTGCCATGAACAG
MEF2D† CAAGCTGTTCCAGTATGCCAG
M-cadherin CAGGTTCACCATCCTTGAAGGT
ACHR-g CAGCGCAATGGATTAGTGCAGG
NCAM (MSD) TCCTCCACAGGCTCCTGCTAAC
MLC1F AAAGACGTGAAGAAGCCCGCTG
a skeletal actin TTATCGGTATGGAGTCTGCGGG
MCK TTCGGCAACACCCACAACAAGTTC
MHC-embryonic GCAAAGACCCGTGACTTCACCTCTAG
MHC-perinatal GAAGACCGCAAGAATGTGCTCC
PAX-1‡ CACATTCAGTCAGCAACATCCTG
M-TWIST AGCGGGTCATGGCTAACGTGCGGGA
ID-1 CTGGAGCTGAACTCGGAGTCTG
Gli§ CTGATTTCAGGGAAGAGAGCAGACTGA
Urokinase GTCTGTAGACCAACAAGGCTTCC
GAPDH GTGGCAAAGTGGAGATTGTTGCC
*Hannon et al., 1992; †Martin et al., 1994; ‡Fan and Tessier-Lavigne, 1994; §Wand differentiation. The effects of the MRF4bh1 mutation on rib
morphogenesis are contrasted with those of mutations in
myogenin and Myf-5; myotomal cellular domains and specific
signaling molecules produced from them are considered as
candidates for intramyotomal and myotome/sclerotome inter-
actions.
MATERIALS AND METHODS
MRF4 inactivation in ES cells
The linearized targeting plasmid was electroporated into CJ7
embryonic stem (ES) cells followed by selection in the presence of
G418 and Gancyclovir. Selection of homologous recombination events
over other integration sites was facilitated by the presence of two HSV-
tk expression cassettes, one flanking each segment of MRF4 homology.
423 independent clones were isolated, and the clones containing a
single, correct homologous recombination on MRF4 locus were iden-
tified by both Southern hybridization and PCR. From 23 positive
clones, six were selected for injection into mouse blastocysts. Coat
chimeras ranging from 5% to greater than 90% were generated from
six lines, of which two were transmitted to the germline. Heterozygous
progeny were crossed with C57B6 mice. Most developmental time-
points assayed in this work were examined in both independent lines
and no differences in phenotype were detected. 
Genotyping of progeny
Genomic DNA was isolated from either yolk sac or tail biopsies. For
Southern hybridization, 10 m g of DNA was digested with either
BamHI and KpnI restriction enzymes, or BamHI and StuI at 37°C.
DNA was fractionated on 0.8% agarose gel with Tris-Acetate-EDTA
buffer, and then transferred to Hybond-N filter with 10· SSPE. Probe
for hybridization was labeled with [a -32P]dCTP using a random-
primed labeling kit (Boehringer Mannheim) according to the manu-
facturer’s instruction. Hybridization was performed at 68°C overnight
according to the method of Sambrook et al. (1989). For genomic PCR,
1 m g of DNA was used in 29 cycles with the following three primers:
MRF4-forward, GGGAGACTGATGCTCCATGACAGC (from
MRF4 promoter); MRF4-reverse, GTGTTCCTCTCCACTGCT-
GTCGCT (from MRF4 exon 1); PGK-reverse, GCGCTACCGGTG-
GATGTGGAATG (from PGK promoter). used in RT-PCR
Reverse primer Cycle no.
CTGAAGACTGCTGGAGGCTG 27
CGTGATAGATAAGTCTGGAGCTGG 26
TGCAGTCGATCTCTCAAAGCACC 26
CTGGCTTGTGGCAGCCCAGG 28
CCCCGTGAGCCTTCATCC 28
AAGGGATGATGTCACCAGGG 26
TGGGTCGTAGTCTTTGGAGTAGC 26
GTCAGGCACTTGGTTGTAGTGGG 27
CGCTCTGTACTTGACCAGATAGTG 26
ATAACCTCCCTGGTCCTTGTTG 23
CACAGCACGATTGTCGATTGTGG 22
ACATAGTTGGGGTCCAGGTCGTC 22
GCATGTGGAAAAGTGATACGTGG 23
CCTCCTGTGCTTTCCTTCAGCC 22
TGTATACTCCCTGCTGGTTGGAA 25
GGAGCCGGTCCTTACCTAGG 26
CTGAAAGGTGGAGAGGGTGAGG 23
ACAAGCTTATGCAGCTGATCCAGCCTA 26
GGATTATAGGAGCTCTCCTTCGAC 27
GATGATGACCCGTTTGGCTCC 22
alterhouse et al., 1993.
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RNAs were prepared by the method of Chomczynski and Sacchi
(1987) from the trunk (without limb) region of embryos from different
developmental timepoints. Quantitative RT-PCR was carried out
according to the method of Robinson and Simon (1991). Both reverse
transcription and PCR were performed in the same tube in a single
buffer with specific primers. AMV-RT (Promega) was used instead
of MMLV-RT, and Taq antibody (Clontech) was also added to block
Taq activity at lower temperatures. 22-28 cycles were used for
different primer sets as shown in Table 1. An initial titration was
carried out to assure that amplifications at high cycle numbers were
still in linear range and quantitative (A. P. and B. W., unpublished
data). All primer sets were designed to span at least one intron to dis-
tinguish RNA from DNA contamination, and the sizes of the products
were between 200 and 500 bases. For the E18.5 samples, reverse tran-
scription was carried out separately with random hexamer primers
(Pharmacia). 
Whole-mount skeletal staining
Newborn mice were skinned and eviscerated prior to fixation.
Embryos were fixed directly in 100% EtOH. After fixation for 3 days,
carcasses were incubated in acetone for 3 days. Bone and cartilage of
mice or embryos were stained for 3 days at 37°C with a solution con-
taining 0.005% alizirin red S, 0.015% alcian blue 8GX, 5% acetic acid
and 70% ethanol. The samples were incubated in a 20% glycerol/1%
KOH solution for 6 hours at 37°C and then kept at room temperature
until the skeleton was clearly visible through the surrounding tissue.
Frozen sections and antibody staining
Embryos were fixed in 4% paraformaldehyde at 4°C overnight.
Embryos younger than E11 were sunk into 15% sucrose and 7.5%
gelatin in PBS solution and then frozen in OCT (Tissue-Tek). Older
embryos were immediately frozen in OCT. Sections of 10-20 m m
thickness were obtained using a cryostat, and were blocked for 20
minutes in 10% goat serum and 3% BSA in PBS before applying the
primary antibody for 1-3 hours at room temperature. The secondary
antibody solution was applied for 1 hour. Antibodies against myosin
heavy chain, (MF20; 1:10 dilution; mouse IgG2b; Developmental
Studies Hybridoma Bank), striated muscle-specific a actinin (1:400
dilution; mouse IgG1; Sigma), myogenin (F5D; 1:5 dilution; mouse
IgG1; courtesy of W. Wright), and MyoD (1:10 dilution; mouse IgG1;
Novocastra Lab. Ltd.) were used. Secondary antibodies were conju-
gated to fluorescein and specific to mouse IgG isotypes and used as
1:100 dilution in 3% BSA in PBS (Southern Biotechnology Associ-
ates). Images were captured digitally using a confocal microscope
(BioRad). 
Histology
Newborn mice were fixed with 4% paraformaldehyde, dehydrated
gradually with ethanol, and embedded in paraffin. 16 m m sections
were stained with both hematoxylin and eosin. Embryos were frozen
in OCT after fixation with 4% paraformaldehyde, sectioned at 20 m m
thickness, and stained with both hematoxylin and eosin.
RESULTS
Construction of MRF4bh1 mutant mouse strains
Two independent strains of mice were generated in which the
functionally essential bHLH domain of the MRF4 gene was
deleted from the chromosome via targeted homologous recom-
bination in embryonic stem cells and subsequent transmission
into the mouse germline. The targeting plasmid was designed
to create a null allele of MRF4 by replacing codons 40-173 of
MRF4 (Miner and Wold, 1990) with a pgk-neo selectioncassette (Fig. 1A). This eliminates the entire basic-helix-loop-
helix domain which is required for MRF protein dimerization
and DNA binding in biochemical assays (Lassar et al., 1989,
1991) and is also required for myogenic activity in transfec-
tion assays (Tapscott et al., 1988; Yutzey et al., 1990). We call
this the MRF4bh1 allele. Blastocyst injections produced
chimeras from six different targeted embryonic stem cell lines;
two independent cell lines from different electroporation
experiments were ultimately established in the germ line. Het-
erozygous males and females appeared grossly normal and
were fertile. Genotypes of progeny were determined by
Southern hybridization and by PCR of DNA from tail or yolk
sac. Southern blot analysis showed that the map of the targeted
locus is as predicted if homologous recombination occurred
between the vector and the host chromosome, as indicated (Fig.
1B). Additional Southern blot analysis showed the related
downstream Myf-5 locus to be intact and unaffected (data not
shown). Progeny from crosses of MRF4bh1 heterozygotes
harvested during gestation yielded 47 (29%) wild-type, 85
(53%) heterozygous and 28 (18%) homozygous embryos,
results that are within 95% confidence limits for 1:2:1
Mendelian ratios. Homozygous animals died shortly after birth
with 100% penetrance. They showed respiratory distress which
may be the main cause of death. 
MRF4 is an important regulator of early
somitogenesis
Quantitative RT-PCR and immunocytological assays were
used to compare littermates of wild-type, heterozygous, and
homozygous genotypes. The earliest marker of myotomal com-
mitment presently known is Myf-5. Previous in situ hybridiza-
tions have shown that Myf-5 expression in somites is first
detectable at E8, when the first four somites have just formed
(Buckingham, 1992). The RT-PCR analysis performed here
also showed no expression of Myf-5 in wild-type E7.5
embryos, but by E8 (6-7 somites) wild-type (data not shown),
heterozygous, and homozygous MRF4bh1 embryos all showed
comparable levels of Myf-5 expression (Fig. 2A). As expected,
the other MRFs were not yet expressed at this time in het-
erozygous or homozygous embryos. Proper Myf-5 initiation
would suggest that the MRF4 knockout allele we have con-
structed does not exert detectable cis-effects on the Myf-5 gene
which is located 7 kb downstream (Miner and Wold, 1990).
By E9 (13-14 somites) myogenin protein expression (Fig. 2B)
was detected, by immunostaining, in heterozygous and
homozygous MRF4bh1 embryos. We conclude that the earliest
myotome formation is largely unaffected by this MRF4
mutation, and this is consistent with the fact that MRF4 is not
expressed detectably until after E9 (Bober et al., 1991; Hin-
terberger et al., 1991; Smith et al., 1994). 
The earliest mutant phenotype detected in MRF4bh1 animals
was a deficit in myotome development that corresponded in
time with the first wave of MRF4 expression, beginning around
E9 and ending around E11. Quantitative RT-PCR was used to
measure expression of an expanded set of genes normally
expressed in somites at this time. For all studies at E10 and
later, trunk regions were dissected and analyzed without head
and limbs. The intent was to eliminate interference from
MRF4-independent myogenic programs that are active in head
and limb. By E10, expression of Myf-5, myogenin, and MyoD
in the trunk were significantly reduced relative to their levels
3350 A. Patapoutian and others
Fig. 1. Targeted disruption of the MRF4 locus by homologous recombination. (A) Structure
of the wild-type and mutated MRF4 loci. For the targeting vector, the KpnI-StuI fragment of
the MRF4 gene, which contains all coding sequences for the basic HLH domain, was
replaced with a pgk-neo cassette for positive selection in G418. HSV-tk cassettes flanked
the targeting vector’s homologous sequences to maximize the efficiency of negative selection with gancyclovir. Direction of arrows in the
targeting vector represents the direction of transcription units. Exons of MRF4 and Myf-5 genes are shown as black and gray rectangles,
respectively. The transcriptional direction of both MRF4 and Myf-5 genes is from left to right. Abbreviations for restriction enzymes are B,
BamHI; E, EcoRI; K, KpnI; and S, StuI. Restriction enzyme sites in parentheses were lost in the cloning process. (B) Southern hybridization of
genomic DNA. Genomic DNA isolated from tail was digested with BamHI and StuI, fractionated on a 0.8% agarose gel, and transferred to
Hybond-N. Using probe A (see A), 2.3 kb and 3.8 kb bands that represent wild-type and mutated MRF4 alleles, respectively, were detected. 
(C) Genomic DNA PCR. DNA was amplified with locus-specific primers (see Materials and methods) for 29 cycles and analyzed on an agarose
gel. A 1 kb ladder was used as a marker (M).
A
B C Fig. 2. Expression of MRFs in
mice lacking MRF4 during initial
myotome formation. 
(A) Quantitative RT-PCR on
MRF4bh1 homozygous and control
littermates from whole E8
embryos. 6-7 somite stage
homozygous and heterozygous
animals show comparable Myf-5
and control GAPDH levels and no
detectable myogenin and MRF4
expression (*). (B,C) Transverse sections of heterozygous (B) and homozygous (C) E9
(13 somite) embryos showing myogenin protein expression in caudal (young) somites.in wild-type littermates (Fig. 3). When normalized to GAPDH
levels, quantitation of band intensities showed that Myf-5,
myogenin, and MyoD RNA levels in homozygotes were 25%,
8%, and 10% of wild-type levels, respectively. Interestingly,
MRF4, Myf-5, and MyoD levels were reproducibly reduced inthe heterozygotes, suggesting that haploinsufficiency in MRF4
is not compensated by upregulation of other family members
and, moreover, that haploinsuffiency in MRF4 radiates through
the MRF network to include other members. Among down-
stream muscle-specific differentiation genes surveyed,
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Fig. 3. Early MRF4 expression is required for muscle-specific gene
expression in myotomes. Quantitative RT-PCR on MRF4bh1
homozygous and control littermates from E10 and E11 trunk
(without head and limb) embryos with muscle-specific and other non
myotomal somitic genes. At E10 all muscle-specific genes examined
are expressed at lower levels in homozygous animals. Heterozygous
animals also show some downregulation compared to wild-type
littermates. Non-myotomal somitic genes and control GAPDH are
expressed at normal levels in MRF4 knockouts. At E11, muscle-
specific genes are still expressed at reduced levels in MRF4
knockouts, however, the downregulation of some genes, such as
MyoD, is less dramatic compared to that seen at E10.MRF4bh1 homozygotes showed very substantial deficits,
although different genes were affected to different extents. For
example, FGF-6 and M-Cadherin, genes that are interesting
for their potential effects on cell-cell interactions, were
expressed at markedly reduced but still detectable levels (8 and
25% of wild type, respectively). However, the effect on the
embryonic myosin heavy chain (MHC-emb) was more
dramatic, as its RNA appears to be entirely absent from mutant
embryos at E10, even though in wild-type embryos it has accu-
mulated at high levels. Since defects in rib morphogenesis
become evident later in development and might arise from
earlier sclerotomal defects, an array of sclerotomal markers
including Pax-1, M-Twist, Id-1, Gli-1, and Urokinase were also
surveyed. No noticeable effects were detected in any of the
sclerotomal markers tested (Fig. 3).
In wild-type animals, MyoD expression begins gradually at
E9.5 (Smith et al., 1994), and it accumulates to significant
levels by E11 (Sassoon et al., 1989). This is an informative
time to evaluate the impact of MRF4bh1, because MRF4 is con-
currently disappearing from wild-type myotomes. At E11,
MRF members were still expressed at reduced levels in
MRF4bh1/bh1 embryos compared to wild type. However, thereduction was less dramatic than that observed one day earlier.
Quantitation of band intensities normalized to GAPDH showed
Myf-5, myogenin, and MyoD RNA levels in homozygotes were
25%, 21%, and 32% of wild-type levels, respectively. The
picture was similar for muscle-specific differentiation markers.
We conclude that the severe deficit in myotomal myogenesis
observed at E10 is moderated by E11, and this was observed
in both knockout lines (Fig. 3 and data not shown).
An important issue is how the gene expression observed in
whole trunk RNA specimens is distributed among cells of the
developing somite. At one extreme, RNA measurements in
Fig. 3 could reflect differences in levels of gene expression dis-
tributed over identical cellular domains in the mutant and wild
type; at the other extreme, all RNA could be accounted for by
changes in the number and/or type of myotomal cells in mutant
versus wild type. To help discriminate between these possibil-
ities, E11 wild-type and homozygous MRF4bh1 littermates
were sectioned and probed with antibodies to relevant muscle-
specific regulators and structural proteins, including myogenin,
MyoD, a -actinin (Fig. 4), and myosin heavy chain (data not
shown). The myotomes of mutant animals were greatly
reduced in size and cell number. Differentiated myocytes could
be identified by their expression of a -actinin (Fig. 4A,B,G,H).
In the homozygotes, these myocytes were confined mainly to
the dorsal myotomal domain. This was most obvious in caudal
hindlimb level somites which developmentally lag behind the
more mature rostral forelimb somites. By E11, MyoD
expression in wild type and in mutants has begun to accumu-
late (Fig. 4E,F,K,L). At the cellular level, MyoD protein
expression outlines a new and much larger presumptive
myotomal domain in the mutants than that shown with
myogenin or a -actinin, and the MyoD domain was concen-
trated more ventrolaterally. 
Axial myogenesis in MRF4bh1 homozygotes is
grossly normal by E14
By E14, no MRF4 expression in wild-type embryos can be
detected, and it does not reappear until about E16. However,
the period of myotomal myogenesis coincident with the
expression of MyoD, which begins around E10.5, has been
active for several days, and during this time axial muscle mass
has expanded significantly. At E14 the RT-PCR analysis was
again focused on axial musculature. Comparable expression
levels were found for most muscle regulators and structural
genes tested in wild-type, heterozygous and homozygous
MRF4bh1 fetuses from both knockout strains (Fig. 5 and data
not shown). Exceptions were Myf-5 and M-Cadherin, both
expressed at reproducibly reduced levels in mutant animals. At
the cellular level, we observed grossly normal muscle mass
patterns by histological staining of E15 embryos (Fig. 6A,B)
and by muscle-specific antibody staining of both limb muscles
and intercostal muscles (data not shown).
MRF4 has subtle effects on intercostal muscles in
the newborn
To examine the effects of the second wave of MRF4
expression, which starts around E16 and correlates with the
timing of widespread secondary differentiation of muscle, we
examined RNA from the ribcage region of E18.5 and newborn
animals by RT-PCR. MRF4bh1/bh1 animals expressed largely
normal levels of most muscle-specific markers, although a
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Fig. 4. Effects of MRF4
knockout on myotomal
domains at E11.
Transverse sections of
wild-type and MRF4bh1
homozygous E11
littermates stained with
antibodies against a
actinin (A, B, G, H),
myogenin (C, D, I, J),
and MyoD (E, F, K, L).
All panels show dorsal
region of transverse
sections. The ventral
side of embryo is facing
downwards, and the
neural tube is on the
upper left hand corner.
Forelimb-level somites
(A-F) represent more
mature myotomes than
do hindlimb level
somites (G-L). The
number of cells
expressing muscle-
specific markers is
strongly reduced in
homozygous animals. a
actinin expression in
both forelimb (A,B) and
hindlimb (G,H) level
myotomes is reduced to
the dorsal, earlier
forming myogenic cells
in MRF4 knockouts.
Myogenin expression in
the younger hindlimb
level somites (I,J) is restricted to a few cells of the dorsal myotome in the MRF4bh1/bh1 animals. In the forelimb region (C,D), myogenin
expression in the MRF4 knockout starts expanding ventrally; however, it is still in a very restricted region compared to the wild-type littermate.
MyoD expression (E,F,K,L) is the least affected in homozygous animals. Although fewer cells express MyoD in the myotomal region of
MRF4bh1/bh1 animals, the domains of expression are comparable in wild-type and homozygous animals at both limb levels.modest reduction in Myf-5 and some muscle-specific structural
genes was observed (Fig. 5). Similar results were obtained for
RNA isolated from limbs (data not shown). However, exami-
nation of sections from E18.5 and newborn mice revealed that
some intercostal muscles associated with ribs 3-5 were either
disorganized or significantly reduced in fiber number in
MRF4bh1/bh1 animals. This pheontype varied in intensity
among different homozygous animals, and it remains to be
determined whether genetic background is playing a significant
role. In animals displaying the most intense intercostal abnor-
malities, substantial numbers of mononuclear cells were
present in homozygous animals (Fig. 6C,D). Antibody staining
for myosin heavy chain (data not shown) and a actinin showed
that these cells were not differentiated myocytes (Fig. 6E,F).
This effect on myogenesis was not evident prior to the period
of fetal MRF4 expression (Fig. 6A,B).
Rib defects in MRF4 null mutant mice
Homozygous mice showed obvious respiratory distress and
died shortly after birth. Rib defects have been observed previ-
ously in Myf-5- and myogenin-null mutant mice (Braun et al.,
1992; Hasty et al., 1993; Nabeshima et al., 1993). We thereforeexamined whether MRF4-null mutant mice exhibit skeletal
abnormalities, by staining with alizirin red S and alcian blue
to detect bone and cartilage, respectively. In newborn mice
homozygous for MRF4bh1, rib development is severely
disturbed (Fig. 7). The abnormalities include rib bifurcation,
fusion of rib cartilage from adjacent ribs, truncated ribs that
fail to attach to the sternum, and disorganized ossification in
the sternum. Rib foreshortening in ribs 2-12 was usually less
than 20% of total length, and this led to variable failure to join
the sternum. Interestingly, the first and last (13th) ribs were
more dramatically shortened compared with the others. Some
ribs also displayed abnormal angles of extension (Fig. 7G,I).
Finally, the tuberculum anterior that is normally present on the
6th cervical vertebrae was absent in most MRF4bh1/bh1 mice
(83% penetrance). Other skeletal elements, including proximal
regions of ribs and vertebrae appeared to be normal (data not
shown). 
To examine when rib defects develop relative to chondro-
genesis and ossification, E14 embryos were stained with both
alizirin red S and alcian blue. Normally, rib cartilage cytodif-
ferentiation in mice begins at E13, and ossification begins at
E14 (Rugh, 1968). In all genotypes, the skeleton at E14 was
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Fig. 5. Expression of muscle-specific genes in mice lacking MRF4
during late embryogenesis. Quantitative RT-PCR on MRF4 knockout
and control littermates from E14 and E18.5 embryos. RNA was
isolated from the ribcage region of animals, avoiding internal organs
such as heart. At both timepoints, most muscle-specific genes and
control GAPDH show normal levels of expression in homozygous
animals. Myf-5 levels are lower in MRF4bh1/bh1 mice, and no MRF4
expression is observed. M-Cadherin is downregulated in
homozygous animals at E14, while MLC1F and MHC-embryonic are
slightly downregulated at E18.5.entirely cartilaginous except for the clavicle and the earliest
ossification centers of facial bones. However, in homozygous
MRF4bh1 mutants, the rib bifurcations and truncated rib forms
were already clearly visible (Fig. 7J,K). Thus, cytodifferentia-
tion of most rib cartilage occurred at the normal time by this
measure, and major rib pattern formation defects were clearly
visible as soon as chondrogenesis rendered rib anlagen histo-
chemically visible. These events occur well before the second
period of MRF4 expression that begins at E16. 
DISCUSSION
In this study the mouse MRF4 (herculin/Myf-6) gene was
disrupted by targeted recombination. Animals homozygous for
this MRF4bh1 allele, which deletes the bHLH domain,
displayed phenotypic effects on axial myogenesis and on rib
pattern formation. They ultimately died at birth of apparent res-
piratory insufficiency. A substantial failure in myotomal devel-
opment of homozygous mutants was observed, and it corre-
sponded with the early somitic wave of MRF4 expression
(E9-11). At the molecular level this generated a gross buttransient deficiency in expression of other MRFs and some
muscle-specific differentiation genes, including FGF-6 and M-
Cadherin, which may be important in pattern formation and
inductive interactions with the sclerotome (see below). The
early myotomal deficit was largely overcome by subsequent
myotomal expansion after the end of the MRF4 expression
period in the myotome. However, perhaps as a consequence of
the earlier myotomal phenotype, rib pattern formation was
disrupted, and may be the primary cause of lethality. A late
fetal muscle phenotype was also detected in some intercostal
muscles of newborn mice, suggesting a possible effect from
the lack of MRF4 expression that normally begins in muscles
at E16; this might also contribute to lethality in the mutants.
MRF4bh1 reveals three waves of myotomal
expansion, each dependent on a different set of
MRFs
A striking aspect of myotome formation in MRF4bh1 homozy-
gotes was the observation that an entire cellular myotomal
domain appeared to be missing. Comparison of mutant and
wild-type embryos before, during and after the window of
MRF4 somitic expression leads us to propose the model shown
in Fig. 8 for myotome biogenesis in the mouse. It identifies
three different myotomal MRF programs (My1, My2 and My3)
with three waves of myotomal cellular commitment and differ-
entiation that result in production, at the cellular level, of
primary, secondary, and tertiary myotomes. This nomenclature
refers to different spatiotemporal phases of myotome
formation, and should not be confused with primary and
secondary myocytes that refer to embryonic and fetal
myogenic differentiation, respectively. The My1 program is
first and begins at E8; it uses Myf-5 and myogenin. By E9, this
program has produced differentiated myocytes that are
expressing myogenin and structural markers such as cardiac
and skeletal a actin (Buckingham, 1992) in a small domain
that typically includes less than 20 cells per somite at the future
forelimb level. These cells are concentrated dorsally in the
somite. The expression of Myf-5 protein in a domain of this
size and position was recently described in a detailed study by
Smith and Miller (Smith et al., 1994). Previous studies of a
Myf-5 gene disruption (Myf-5m1; Braun et al., 1992, 1994) have
shown that there is no detectable myocyte differentiation in
Myf-5 deficient homozygotes until E10.5. This suggests that
Myf-5 function is essential for the My1 program, and is con-
sistent with expression patterns. Whether myogenin is also
essential for execution of this MRF program is not certain, as
phenotypic data is not yet available for myogenin null mutants
at the early times (Hasty et al., 1993; Nabeshima et al., 1993).
The My1 program is initiated on schedule by both molecular
and cellular assays, in the MRF4bh1 homozygotes (Fig. 2). 
The phenotype of MRF4bh1 homozygotes suggests the
existence of a second MRF program (My2) that is needed to
execute a new wave of myogenic recruitment in the myotome.
This myotomal expansion normally occurs during the period
of MRF4 expression beginning at about E9 in rostral somites,
and involves an increase of at least 15-fold in the number of
cells expressing myogenin or other skeletal muscle markers
(Smith et al., 1994). The most straightforward interpretation of
data from our MRF4 gene disruption is that the proposed
secondary wave of myotomal expansion requires MRF4
function. Myf-5 is also required, because Myf-5m1 homozy-
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Fig. 6. Abnormal intercostal
muscle formation at E18.5
and newborn in MRF4bh1/bh1
mice. Frozen sections of
E15.0 day embryos (A,B) or
sections of paraffin
embedded newborn mice
(C,D) were stained with
hematoxylin/eosin. Unlike
the wild-type mice (C),
disorganized muscle fibers
and an increased number of
mononuclear cells are seen in
intercostal muscle of
newborn MRF4bh1/bh1 mice
(D). However, intercostal
muscle looks similar in both
wild-type (A) and
MRF4bh1/bh1 (B) embryos at
E15. Immunostaining of
intercostal muscles with a
actinin antibody shows
MRF4bh1/bh1 mice (F) have
abnormal muscle formation
between ribs compared to
wild-type littermate (E) at
E18.5 (r, rib).gotes form neither the proposed primary or secondary
myotomes, nor do they turn on MRF4 or other muscle-specific
genes during this time (Braun et al., 1994). It is not clear,
however, whether the dependence of secondary myotome
formation on Myf-5 is cell autonomous or not. Thus in one
scenario, Myf-5 expressing myoblasts within the primary
myotome would migrate, change their MRF expression pattern
(including initiation of MRF4 expression) and then form the
secondary myotome. In a nonautonomous mechanism, meso-
dermal precursor cells neighboring the primary myotome could
be directly induced to express MRF4 and myogenin and thus
commence formation of the secondary myotome. In either
case, MyoD is not widely expressed until later times, and does
not significantly compensate. It is interesting that myogenin
null embryos apparently show normal somitic and myotomal
morphology during the My2 program, and it will now be useful
to examine muscle-specific gene expression between E8.5 and
E10.5 in myogenin knockout mice to see whether the
secondary wave of muscle differentiation proposed here occurs
normally. 
The proposed My3 program is marked by the onset of MyoD
expression, and prominent myogenin expression. Together,
they appear sufficient to direct a third major cellular expansion
that produces the tertiary myotome of Fig. 8 between E11.5
and 15. Thus, in Myf-5m1 null embryos, there is no detectable
myotome formation until the onset of MyoD expression aroundE10.5, but that following onset of its expression a large
myotome quickly forms, and subsequent axial myogenesis
appears surprisingly normal (Braun et al., 1994). This led those
investigators to propose the regulatory and functional inde-
pendence of a MyoD driven myotome, and data presented here
lead us to identify it as the third of three waves of myogene-
sis in the mouse myotome. MRF4 is not detectably expressed
during most of the My3 period, nor is there any evidence that
it can be accessed to compensate for MyoD when MyoD has
been mutated (Rudnicki et al., 1992). However, in the MRF4bh1
homozygotes, the timing of the MyoD dependent myotome
expansion was somewhat delayed, suggesting the possibility of
positive inductive interaction between My2 and My3. Myf-5
expression normally declines between E11 and 16, and its
domain of expression does not appear to fully overlap the
expanded area in which MyoD and myogenin are prominent
(Smith et al., 1994). However, in MyoD knockout mice, Myf-
5 appears to compensate (Rudnicki et al., 1992); it is expressed
at relatively elevated levels in these animals for an extended
period and they ultimately appear to have normal axial mus-
culature. This is one of several situations in which it is unclear
whether compensation is at the level of cells or at the level of
MRF molecules. Thus, compensation might represent the
expansion of a pool of cells that express Myf-5 and myogenin
or might instead reflect crosstalk among MyoD family regula-
tors within a cell. 
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Fig. 7. Skeletal defects in MRF4bh1/bh1 mice. Skeletons of wild type and MRF4bh1/bh1 mice were stained with alizirin red S and alcian blue.
(A,B) Ventral view of thoracic region of wild-type (A) and MRF4bh1/bh1 (B) newborn mice. While the first seven ribs are attached to the
sternum in wild-type mice, only a few ribs are connected in MRF4bh1/bh1 mice. Anomaly of xiphoid process and severe truncation of first rib is
also seen in MRF4bh1/bh1 mice (arrows). (C,D) Ventral view of lower thoracic vertebrae of newborn mice. Unlike wild type (C), the 13th rib
appears as an anlage in MRF4bh1/bh1 (D, arrow). (E,F) Lateral view of cervical vertebrae of newborn mice. In MRF4bh1/bh1 (F), the tuberculum
anterior on the 6th cervical vertebra is missing, and a very truncated first rib is observed (arrows). (G-I) Lateral view of thoracic region of
newborn MRF4bh1/bh1 mice. MRF4bh1/bh1 skeletons show a bifurcation, a fusion, and abnormal angle of rib extension (arrows). (J,K) Lateral
view of thoracic region of E14 embryo. Rib defect is already obvious at E14 in the MRF4bh1/bh1 embryo (K, arrows). Abbreviations: xp,
xiphoid process; r, rib; t, thoracic vertebrae; c, cervical vertebrae.Rib pattern formation phenotypes in MRF4bh1/bh1
mice
The rib morphogenesis phenotypes in the MRF4bh1 homozy-
gotes are quite different from those of the Myf-5m1 homozy-
gotes and are more similar to the myogenin null rib defects.
The Myf-5 mutant has only rudimentary rib stumps at all
vertebrae, but the MRF4bh1 homozygotes have extensive rib
formation that is mainly disrupted at distal locations close to
the sternum. This suggests that the basis for the pattern
formation disturbances in these animals are mainly interactions
between myotome and sclerotome that depend on cells and
signals produced in the My2 myotome of the model, while the
more dramatic reduction in rib formation found in the Myf-5
mutant might be attributable to failure of the My1 program.
Christ and colleagues (Huang et al., 1994) have recently
reported that in the chick-quail system, cells from the somito-
coele of early epithelial somites are rib progenitors. Moreover,
homotypic somitic transplantation experiments revealed that
rib progenitors from one somite can later be found in two ribs;
the transplanted somite and the next most rostral rib. At slightly
later developmental times, cytological studies have noted the
close apposition of lateral sclerotomal cells to the emerging
myotome. It is interesting to speculate that cells of the
secondary (and perhaps primary) myotome, as shown in Fig. 8,
provide signals and cellular scaffolding as these cells elongatein the rostral caudal axis; and if these signals or cellular scaf-
folding are underdeveloped, migration of rib progenitors may
be obstructed, and later reflected as the bifurcations and spurs
(Fig. 4). 
Candidate signaling molecules
A candidate signaling molecule that could mediate inductive
interactions within the expanding myotome or between
myotome and sclerotome was suggested by results presented
here. FGF-6 is specifically expressed in myotomes starting at
E9.5, about the same time that MRF4 starts to accumulate (Han
and Martin, 1993; deLapeyriere et al., 1993). FGF-6 belongs
to the family of fibroblast growth factors, and here we demon-
strate that its levels are strongly downregulated in myotomes
of MRF4 null mice (8% of wild type). Although the specific
functions of FGF-6 are not presently known, it is an attractive
candidate for intercellular signaling between cells of the
myotome and the pool of proliferating precursors that are being
recruited to the expanding myotome throughout its maturation.
A second plausible interaction is with adjacent sclerotomal
cells that are thought to include rib progenitors. Therefore, it
is potentially relevant that FGF family receptors such as
FGFR-1 and FGFR-2 are expressed in sclerotomal cells (Peters
et al., 1992; Yamaguchi et al., 1992), but no known candidate
ligands have been identified within the sclerotome itself. This
raises the possibility that FGF-6 secreted from myotomes
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MRF4might act as the ligand for these receptors. The possibility of
involvement of the FGF family in rib development is also
suggested by recent findings of several inherited human
skeletal disorders that correlate with mutations in FGF
receptors, including FGFR1 and 2 (reviewed by Eriebacher et
al., 1995). 
The skeletal and myogenic phenotypes of MRF4bh1/bh1 mice
resemble phenotypes of mutations in two genes involved in
cell-cell inductive interactions. Follistatin interacts with
activin/inhibin, and modulates its function (reviewed by
DePaolo et al., 1991). In follistatin null mutant mice the 13th
rib is absent and, in some genetic backgrounds, the 7th rib fails
to attach to the sternum (Matzuk et al., 1995). In addition, inter-
costal muscles of newborn follistatin null mice showed sparse
and somewhat disorganized muscle fibers, similar to MRF4
null mice. The expression pattern of follistatin is also sugges-
tive of a role in musculoskeletal interactions. It appears in
somites prior to MRF4 expression (Albano et al., 1994; Feijen
et al., 1994), opening the possibility that it acts upstream of
MRF4; it will be informative to study how MRF4 and Myf-5
are expressed in somites of follistatin null mice. BMP5 is one
of the large family of bone morphogenetic factors related to
TGFb . In BMP5 null mice, the 13th rib and the tuberculum
anterior of the sixth cervical vertebra are absent (Kingsley et
al., 1992), two features also found in MRF4bh1/bh1 animals.
BMP5 is expressed widely in skeletal precursors (King et al.,
1994), and it remains to be determined whether its expression
is altered in MRF4 null mutants.
Cis and trans interactions between MRF4 and Myf-5
Myf-5 and MRF4 are located only 7 kb apart on the chromo-
some (Miner and Wold, 1990), while myogenin and MyoD are
unlinked. This raises the possibility that changes at the MRF4
locus, which in this study included deletion of
protein coding and first intron sequences as well
as insertion of a neo selection cassette, might
exert effects on Myf-5 in cis. A recent study by
Arnold and colleagues provides evidence for such
complex cis interactions (Braun and Arnold,
1995). They found that a disruption designed to
remove a segment of MRF4 that is entirely
upstream (5¢ ) of that deleted in MRF4bh1 allele
unexpectedly eliminated virtually all Myf-5
expression and function. This led to a phenocopy
of the Myf-5m1/m1 rib and myotome defects. It is
clear that early Myf-5 expression, which defines
the start of the My1 program in our model, was
indistinguishable from wild type in the MRF4bh1
disruption (Fig. 2). Moreover, the bh1 rib defects
were clearly not a phenocopy of the more
extreme Myf-5 deficiency. In addition, we Wildtype
Age
MRF
Expression
MRF Progr
Model for MRF4bh1/
* MRF expre
Fig. 8. A summary model is proposed for myotome
formation in the mouse and the role of MRF regulators
in this process. It is based on the molecular and
histological phenotypes of the various MRF knockouts
and on the expression patterns of the MRFs according
to previous in situ hybridization studies and
immunohistochemical staining (reviewed by
Buckingham, 1992; Smith et al., 1994). See the
discussion for details and explanation.observe significant expression of Myf-5 at later developmental
times, which further distinguishes it from the allele of Braun
and Arnold (1995). We conclude that the MRF4bh1 allele does
not generate a wholesale cis disruption of Myf-5 expression.
However, cis effects could be a part of the myotomal
MRF4bh1/bh1 phenotype, if such cis effects operate on a specific
subset of Myf-5 expression that mainly overlaps spatiotempo-
rally with MRF4 expression in the wild type. Such cis effects
on Myf-5 could also explain the RT-PCR data from E14
embryo trunks where, unlike MyoD and myogenin, Myf-5
expression remains at lower levels in MRF4bh1/bh1 embryos
than in wild type. However, this remains only one interpreta-
tion, as at this late embryonic stage, Myf-5 expression in wild
type is dropping relative to other MRFs and may therefore
simply not play a significant part in the MyoD directed My3
program. A third MRF4 allele has been generated concurrently
with these (Zhang et al., 1995). This allele removed a larger
segment of protein coding sequence than in the bh1 allele,
including some 3¢ flanking sequences, and it also left a pgk-
neo cassette behind, though in different orientation. It
displayed a rib phenotype similar in pattern formation
character to MRF4bh1/bh1 but with a far milder effect at the
point of joining to the sternum. Apparently owing to the milder
rib phenotype, homozygotes of this mutation were viable, and
this permitted studies of adult muscle where a five-fold relative
upregulation of myogenin RNA was observed, suggesting com-
pensation for the deficit in MRF4. It will now be interesting to
compare early somitic myogenesis in the two alleles prior to
E11.5. Also, given the uncertainties attached to both positive
and negative regulatory influences originating from the
selection cassette enhancer/promoter residue present in all
three MRF4 mutations and in the Myf-5m1 allele, analysis of
this locus will benefit from new methods that allow for nearlybh1
1o Myotome 2o Myotome 3o Myotome
ssion and myotomal domains represent forelimb level somites
3357MRF4 disruption causes myotome and rib defectscomplete excision of targeting vector residue (reviewed by
Sauer, 1993).
Additional questions concerning the lineage, fate and
function of cells of the embryonic myotome are raised by our
results. With respect to the fate of cells from the 1o or 2o
myotome in later development, we are not aware of any cell
tracing experiments that could tell us how long they live,
whether they expand their domain, nor exactly where these
cells might be located in the mature musculature. The cells
appear to be mainly mononucleate myocytes and, by their cell
number alone, they cannot make a major contribution to the
mature axial musculature. The observation that rib defects
occur in knockouts of any of the three MRFs that are expressed
in the primary or secondary myotomes, together with the
capacity of the tertiary myotome to compensate for lack of the
previous two in later muscle formation, suggests that the early
myotome may be mainly important as an inductive regulator
and pattern formation guide for rib anlagen. 
In a broader context, analysis of the MRF4bh1 mutant under-
scores the dynamic quality of the somite. We have proposed
that different combinations of MyoD family genes are needed
to support distinct waves of cellular commitment and muscle
differentiation, but why is the myotome built up in this appar-
ently piecemeal fashion? One reason could be to limit muscle
differentiation to specific subsets of precursors at early times,
while others in the same signaling microenvironment are
permitted to proliferate further. Also, at different times in the
growth and maturation of the myotome, the sources of
inductive and inhibitory interactions driving muscle determi-
nation and differentiation such as neural tube, sclerotome,
earlier myotome or dermatome are themselves changing
rapidly and are likely to be expressing different signals. Thus
the multiplicity of MRFs may be most important, at least in the
embryo, because they provide for myogenic responses to
separate signaling pathways. The complexity and develop-
mental diversity of cis regulatory elements currently being
identified in MRF genes provides indirect support for this view
(Patapoutian et al., 1993; Cheng et al., 1993; Yee and Rigby,
1993; Goldhammer et al. 1995), while direct tests may require
gene transplacement experiments in which one MRF protein
coding sequence replaces another in the mouse germline. 
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Notes added in proof
(1) The MRF4bh1 mouse line has been accepted by the Jackson
Laboratory Genetic Resource Committee, and it will be dis-
tributed through the Jackson Laboratory. (2) We have recently
observed one apparently healthy homozygous MRF5bh1/bh1
adult animal. Ongoing studies are needed to clarify whether
this represents a low penetrance event or instead reflects a
change in genetic background that is part of the breeding
program.
